SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cencora, Inc. – ‘10-K’ for 9/30/23 – ‘EX-97’

On:  Tuesday, 11/21/23, at 4:21pm ET   ·   For:  9/30/23   ·   Accession #:  1140859-23-197   ·   File #:  1-16671

Previous ‘10-K’:  ‘10-K’ on 11/22/22 for 9/30/22   ·   Latest ‘10-K’:  This Filing   ·   55 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/21/23  Cencora, Inc.                     10-K        9/30/23  109:11M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.04M 
13: EX-4.16     Instrument Defining the Rights of Security Holders  HTML     46K 
 2: EX-21       Subsidiaries List                                   HTML     33K 
 3: EX-23       Consent of Expert or Counsel                        HTML     31K 
12: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     50K 
                Awarded Compensation                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     32K 
14: R1          Cover                                               HTML     95K 
15: R2          Audit Information                                   HTML     35K 
16: R3          Consolidated Balance Sheets                         HTML    150K 
17: R4          Consolidated Balance Sheets (Parenthetical)         HTML     44K 
18: R5          Consolidated Statements of Operations               HTML    135K 
19: R6          Consolidated Statements of Comprehensive Income     HTML     65K 
20: R7          Consolidated Statements of Changes in               HTML    100K 
                Stockholders' Equity                                             
21: R8          Consolidated Statements of Changes in               HTML     53K 
                Stockholders' Equity (Parenthetical)                             
22: R9          Consolidated Statements of Cash Flow                HTML    144K 
23: R10         Summary of Significant Accounting Policies          HTML     95K 
24: R11         Acquisitions and Equity Method Investment           HTML     73K 
25: R12         Variable Interest Entity                            HTML     52K 
26: R13         Income Taxes                                        HTML    121K 
27: R14         Goodwill and Other Intangible Assets                HTML     74K 
28: R15         Debt                                                HTML     73K 
29: R16         Stockholders' Equity and Weighted Average Common    HTML     52K 
                Shares Outstanding                                               
30: R17         Related Party Transactions                          HTML     35K 
31: R18         Retirement and Other Benefit Plans                  HTML     39K 
32: R19         Share-Based Compensation                            HTML     70K 
33: R20         Leases                                              HTML     70K 
34: R21         Restructuring and Other Expenses                    HTML     44K 
35: R22         Legal Matters and Contingencies                     HTML     52K 
36: R23         Litigation Settlements                              HTML     33K 
37: R24         Business Segment Information                        HTML    111K 
38: R25         Fair Value of Financial Instruments                 HTML     34K 
39: R26         Subsequent Event                                    HTML     32K 
40: R27         Schedule Ii??? Valuation and Qualifying Accounts    HTML     49K 
41: R28         Pay vs Performance Disclosure                       HTML     42K 
42: R29         Insider Trading Arrangements                        HTML     35K 
43: R30         Summary of Significant Accounting Policies          HTML    127K 
                (Policies)                                                       
44: R31         Summary of Significant Accounting Policies          HTML     66K 
                (Tables)                                                         
45: R32         Acquisitions and Equity Method Investment (Tables)  HTML     65K 
46: R33         Variable Interest Entity (Tables)                   HTML     55K 
47: R34         Income Taxes (Tables)                               HTML    119K 
48: R35         Goodwill and Other Intangible Assets (Tables)       HTML    101K 
49: R36         Debt (Tables)                                       HTML     58K 
50: R37         Stockholders' Equity and Weighted Average Common    HTML     49K 
                Shares Outstanding (Tables)                                      
51: R38         Share-Based Compensation (Tables)                   HTML     68K 
52: R39         Leases (Tables)                                     HTML     74K 
53: R40         Restructuring and Other Expenses (Tables)           HTML     42K 
54: R41         Business Segment Information (Tables)               HTML    106K 
55: R42         Summary of Significant Accounting Policies -        HTML     74K 
                Recently Adopted Accounting Pronouncements                       
                (Details)                                                        
56: R43         Summary of Significant Accounting Policies -        HTML     44K 
                Schedule of Restricted Cash (Details)                            
57: R44         Summary of Significant Accounting Policies -        HTML     41K 
                Concentrations of Credit Risk (Details)                          
58: R45         Summary of Significant Accounting Policies -        HTML     60K 
                Foreign Currency (Details)                                       
59: R46         Summary of Significant Accounting Policies -        HTML     35K 
                Goodwill and Other Intangible Assets (Details)                   
60: R47         Summary of Significant Accounting Policies -        HTML     35K 
                Inventories (Details)                                            
61: R48         Summary of Significant Accounting Policies -        HTML     42K 
                Property and Equipment (Details)                                 
62: R49         Summary of Significant Accounting Policies -        HTML     45K 
                Schedule of Property and Equipment (Details)                     
63: R50         Summary of Significant Accounting Policies -        HTML     31K 
                Revenue Recognition (Details)                                    
64: R51         Summary of Significant Accounting Policies -        HTML     34K 
                Shipping and Handling Costs (Details)                            
65: R52         Acquisitions and Equity Method Investment -         HTML    132K 
                Additional Information (Details)                                 
66: R53         Acquisitions and Equity Method Investment - Fair    HTML     48K 
                Value Of Intangible Assets (Details)                             
67: R54         Acquisitions and Equity Method Investment - Assets  HTML    101K 
                And Liabilities (Details)                                        
68: R55         Variable Interest Entity - Schedule of Assets and   HTML     87K 
                Liabilities of Profarma (Details)                                
69: R56         Income Taxes - Income Before Income Taxes           HTML     39K 
                (Details)                                                        
70: R57         Income Taxes - Income Tax Expense (Details)         HTML     58K 
71: R58         Income Taxes - Tax Rate Reconciliation (Details)    HTML     50K 
72: R59         Income Taxes - Additional Information (Details)     HTML     78K 
73: R60         Income Taxes - Significant Components of Deferred   HTML     72K 
                Tax Liabilities (Assets) (Details)                               
74: R61         Income Taxes - Reconciliation of Unrecognized Tax   HTML     44K 
                Benefits (Details)                                               
75: R62         Goodwill and Other Intangible Assets - Changes in   HTML     55K 
                Carrying Value of Goodwill (Details)                             
76: R63         Goodwill and Other Intangible Assets - Additional   HTML     70K 
                Information (Details)                                            
77: R64         Goodwill and Other Intangible Assets - Other        HTML     55K 
                Intangible Assets (Details)                                      
78: R65         Debt - Debt Instruments (Details)                   HTML     96K 
79: R66         Debt - Additional Information (Details)             HTML    143K 
80: R67         Stockholders' Equity and Weighted Average Common    HTML     83K 
                Shares Outstanding - Additional Information                      
                (Details)                                                        
81: R68         Stockholders' Equity and Weighted Average Common    HTML     46K 
                Shares Outstanding - Components of Accumulated                   
                Other Comprehensive Loss (Details)                               
82: R69         Stockholders' Equity and Weighted Average Common    HTML     38K 
                Shares Outstanding - Components of Diluted                       
                Weighted Average Shares Outstanding (Details)                    
83: R70         Related Party Transactions (Details)                HTML     50K 
84: R71         Retirement and Other Benefit Plans (Details)        HTML     50K 
85: R72         Share-Based Compensation - Additional Information   HTML     89K 
                (Details)                                                        
86: R73         Share-Based Compensation - Stock Options (Details)  HTML     69K 
87: R74         Share-Based Compensation - Nonvested Options        HTML     40K 
                (Details)                                                        
88: R75         Share-Based Compensation - Nonvested Restricted     HTML     54K 
                Stock Units (Details)                                            
89: R76         Share-Based Compensation - Nonvested Performance    HTML     54K 
                Stock Units (Details)                                            
90: R77         Leases - Lease Cost (Details)                       HTML     38K 
91: R78         Leases - Summary of Balance Sheet Information       HTML     50K 
                Related to Leases (Details)                                      
92: R79         Leases - Other Cash Flow Information related to     HTML     36K 
                Operating Leases (Details)                                       
93: R80         Leases - Future Minimum Rental Payments Under       HTML     50K 
                Noncancelable Operating Leases (Details)                         
94: R81         Restructuring and Other Expenses - Schedule of      HTML     39K 
                Restructuring and Other Expenses (Details)                       
95: R82         Restructuring and Other Expenses - Additional       HTML     37K 
                Information (Details)                                            
96: R83         Legal Matters and Contingencies (Details)           HTML     62K 
97: R84         Litigation Settlements (Details)                    HTML     31K 
98: R85         Business Segment Information - Additional           HTML     42K 
                Information (Details)                                            
99: R86         Business Segment Information - Segment Revenue      HTML     54K 
                (Details)                                                        
100: R87         Business Segment Information - Segment Operating    HTML     52K  
                Income (Details)                                                 
101: R88         Business Segment Information - Reconciliation of    HTML     71K  
                Total Segment Operating Income to Income from                    
                Continuing Operations before Income Taxes                        
                (Details)                                                        
102: R89         Fair Value of Financial Instruments (Details)       HTML     41K  
103: R90         Subsequent Event (Details)                          HTML     34K  
104: R91         Schedule Ii??? Valuation and Qualifying Accounts    HTML     38K  
                (Details)                                                        
107: XML         IDEA XML File -- Filing Summary                      XML    198K  
105: XML         XBRL Instance -- cor-20230930_htm                    XML   2.21M  
106: EXCEL       IDEA Workbook of Financial Report Info              XLSX    218K  
 8: EX-101.CAL  XBRL Calculations -- cor-20230930_cal                XML    309K 
 9: EX-101.DEF  XBRL Definitions -- cor-20230930_def                 XML    877K 
10: EX-101.LAB  XBRL Labels -- cor-20230930_lab                      XML   2.58M 
11: EX-101.PRE  XBRL Presentations -- cor-20230930_pre               XML   1.52M 
 7: EX-101.SCH  XBRL Schema -- cor-20230930                          XSD    219K 
108: JSON        XBRL Instance as JSON Data -- MetaLinks              716±  1.06M  
109: ZIP         XBRL Zipped Folder -- 0001140859-23-000197-xbrl      Zip    610K  


‘EX-97’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 97
Dodd-Frank Compensation Recoupment Policy of
Cencora, Inc.
Adopted as of November 8, 2023, with retroactive effectiveness from October 2, 2023
Section 1.    Purpose.
Cencora, Inc. (the “Company”) has adopted this Compensation Recoupment Policy (this “Policy”) to implement a mandatory clawback policy in the event of a Restatement in compliance with the applicable rules of the NYSE.
Any capitalized terms used, but not immediately defined, in this Policy have the meanings set forth in Section 14.
Section 2.    Administration.
This Policy shall be administered in the sole discretion of the Committee. The Committee shall have the discretion to interpret this Policy and make all determinations with respect to this Policy, consistent with applicable law and this Policy. Without limiting the foregoing this Policy shall be interpreted in a manner that is consistent with the requirements of the Applicable Rules, and compliance with this Policy shall not be waived by the Committee, the Board or the Company in any respect. Any interpretations and determinations made by the Committee shall be final and binding on all affected individuals.
Section 3.    Effective Date.
This Policy is effective as of October 2, 2023 (the “Effective Date”). This Policy applies to Incentive-Based Compensation that is Received by any Executive Officer on or after the Effective Date as described in Section 7 below.
Section 4.    Amendment.
The Committee may amend this Policy from time to time in its discretion, subject to any limitations under applicable law or listing standards, including the Applicable Rules. Without limiting the forgoing, the Committee may amend this Policy as it deems necessary to reflect any amendment of the Applicable Rules or regulations or guidance issued under the Applicable Rules.
Section 5.    No Substitution of Rights; Non-Exhaustive Rights.
Any right of recoupment under this Policy is in addition to, and not in lieu of, any other remedies or rights that may be available to the Company pursuant to (a) the Company’s Omnibus Incentive Plan, 2022 Omnibus Incentive Plan, or any successor plan thereto, the Company’s Annual Incentive Plan, or any other incentive plan or policy of the Company or any of its subsidiaries, (b) the terms of any recoupment policy or provision in any employment agreement, compensation agreement or arrangement, or other agreement or arrangement, (c) the Company’s Financial Recoupment Policy, which applies to certain businesses pursuant to the Corporate Integrity Agreement, dated September 28, 2018, entered into by the Company with the Office of Inspector General of the United States Department of Health and Human Services, (d) the Company’s Discretionary Compensation Recoupment Policy (the “Discretionary Recoupment Policy”) or (e) any other legal remedies available to the Company under applicable law.



In addition to recovery of compensation as provided for in this Policy, the Company may take any and all other actions as it deems necessary, appropriate and in the Company’s best interest in connection with the Committee determining that this Policy should apply, including termination of the employment of, or initiating legal action against, an Executive Officer, and nothing in this Policy limits the Company’s rights to take any such appropriate actions.
Section 6.    Recovery on a Restatement.
In the event that the Company is required to prepare a Restatement, the Company shall reasonably promptly recover from an Executive Officer the amount of any erroneously awarded Incentive-Based Compensation that is Received by such Executive Officer during the Recovery Period. The amount of erroneously Received Incentive-Based Compensation will be the excess of the Incentive-Based Compensation Received by the Executive Officer (whether in cash or shares) based on the erroneous data in the original financial statements over the Incentive-Based Compensation (whether in cash or in shares) that would have been Received by the Executive Officer had such Incentive-Based Compensation been based on the restated results, without respect to any tax liabilities incurred or paid by the Executive Officer.
Recovery of any erroneously awarded compensation under this Policy is not dependent on fraud or misconduct by any Executive Officer in connection with a Restatement.
Without limiting the foregoing, for Incentive-Based Compensation based on the Company’s stock price or total shareholder return, where the amount of erroneously awarded compensation is not subject to mathematical recalculation directly from the information in the Restatement, (a) the amount shall be based on the Company’s reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received and (b) the Company shall maintain documentation of the determination of that reasonable estimate and provide such estimate to the Regulators as required by the Applicable Rules.
In addition to the foregoing, in the event that an Executive Officer fails to promptly repay or reimburse erroneously awarded compensation that is subject to recovery, the Committee may require the Executive Officer to reimburse the Company for any and all expenses reasonably incurred (including legal fees) by the Company in recovering erroneously awarded compensation under this Policy.
Section 7.    Covered Executive Officers and Covered Incentive-Based Compensation.
This Policy covers all persons who are Executive Officers at any time during the Recovery Period for which Incentive-Based Compensation is Received or during the performance period applicable to such Incentive-Based Compensation. Incentive-Based Compensation shall not be recovered under this Policy to the extent it was Received by any person before the date the person was determined to have begun serving as an Executive Officer. Subsequent changes in an Executive Officer’s employment status, including retirement or termination of employment, do not affect the Company’s right to recover Incentive-Based Compensation pursuant to this Policy.
This Policy shall apply to Incentive-Based Compensation that is Received by any Executive Officer on or after the Effective Date and that results from attainment of a Financial Reporting Measure based on or derived from financial information for any fiscal period ending on or after the Effective Date. For the avoidance of doubt, this will include Incentive-Based Compensation that may have been approved, awarded or granted to an Executive Officer on or before the Effective Date if such Incentive-Based Compensation is Received on or after the Effective Date.



Section 8.    Limited Exceptions to Recovery.
The Committee shall determine, in its sole discretion, the method of recovering any Incentive-Based Compensation subject to this Policy, including those methods set forth in Section 10.
No recovery shall be required if any of the following conditions are met and the Committee determines that, on such basis, recovery would be impracticable:
(a)the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered; provided that prior to making a determination that it would be impracticable to recover any Incentive-Based Compensation based on the expense of enforcement, the Company shall (i) have made a reasonable attempt to recover the Incentive-Based Compensation, (ii) have documented such reasonable attempts to recover, and (iii) provide the documentation to the NYSE;
(b)recovery would violate home country law where that law was adopted prior to November 28, 2022; provided that, prior to making a determination that it would be impracticable to recover any Incentive-Based Compensation based on a violation of home country law, the Company shall (i) have obtained an opinion of home country counsel, acceptable to the NYSE, that recovery would result in such violation, and (ii) provide a copy of such opinion to the NYSE; or
(c)recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees, to fail to meet the requirements of Section 401(a)(13) or Section 411(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and U.S. Treasury regulations promulgated thereunder.
Section 9.    Reporting; Disclosure; Monitoring.
The Company shall make all required disclosures and filings with the Regulators with respect to this Policy in accordance with the requirements of the Applicable Rules, and any other requirements applicable to the Company, including the disclosures required in connection with SEC filings.
Section 10.    Methods of Recovery.
Subject to Section 8, in the event that the Committee determines that this Policy should apply, to the extent permitted by applicable law, the Company shall, as determined by the Committee in its sole discretion, take any such actions as it deems necessary or appropriate to recover Incentive-Based Compensation. The actions may include, without limitation (and as applicable), any method of recovery described in the Discretionary Recoupment Policy and/or any of the following:
(a)forfeit, reduce or cancel any Incentive-Based Compensation (whether vested or unvested) that has not been distributed or otherwise settled;
(b)seek recovery of any Incentive-Based Compensation that was previously paid to the Executive Officer;
(c)seek recovery of any amounts realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based Incentive-Based Compensation;
(d)recoup any amount in respect of Incentive-Based Compensation that was contributed or deferred to a plan that takes into account Incentive-Based Compensation (excluding certain tax-qualified plans, but including deferred compensation plans, supplemental executive retirement plans, and insurance plans to the extent otherwise permitted by applicable law, including Section 409A of the Code) and any earnings accrued on such Incentive-Based Compensation;



(e)offset, withhold, eliminate or cause to be forfeited any amount that could be paid or awarded to the Executive Officer after the date of determination; and/or
(f)take any other remedial and recovery action permitted by law, as determined by the Committee.
In addition, the Committee may authorize legal action for breach of fiduciary duty or other violation of law and take such other actions to enforce the obligations of the Executive Officer to the Company as the Committee deems appropriate.
Section 11.    Notice.
Before the Company takes action to seek recovery of compensation pursuant to this Policy or any other action provided for under this Policy against an Executive Officer, the Company shall take commercially reasonable steps to provide such individual with advance written notice of such clawback; provided that this notice requirement shall not in any way delay the reasonably prompt recovery of any erroneously awarded Incentive-Based Compensation.
Section 12.    No Indemnification.
Neither the Company nor any of its subsidiaries shall indemnify any current or former Executive Officer against the loss of erroneously awarded compensation, and neither the Company nor any of its subsidiaries shall pay or reimburse any such person for premiums incurred or paid for any insurance policy to fund such person’s potential recovery obligations.
Section 13.    Governing Law.
This Policy and all determinations made and actions taken pursuant hereto, to the extent not otherwise governed by mandatory provisions of the Applicable Rules, shall be governed by and construed in accordance with the laws of the State of Delaware without regard to choice of law principles. If any provision of this Policy shall be held illegal or invalid for any reason, such illegality or invalidity shall not affect the remaining parts of this Policy, but this Policy shall be construed and enforced as if the illegal or invalid provision had never been included in this Policy.
Section 14.    Defined Terms.
The following capitalized terms used in this Policy have the following meanings:
(a)Applicable Rules” means Section 10D of the Exchange Act and Rule 10D-1 promulgated thereunder and Section 303A.14 of the Listed Company Manual of the NYSE.
(b)Board” means the Board of Directors of the Company.
(c)Committee” means the Compensation and Succession Planning Committee of the Company, or, in the absence of such committee, a majority of independent directors serving on the Board.
(d)Exchange Act” means the Securities Exchange Act of 1934, as amended.
(e)Executive Officer” means each person who is identified as an “executive officer,” as defined in Rule 10D-1(d) under the Exchange Act and Section 303A.14(e) of the Listed Company Manual of the NYSE, which would include any president, principal financial officer or principal accounting officer (or if there is no such accounting officer, the controller) of the Company or any of its subsidiaries, any vice president of the Company or any of its subsidiaries in charge of a principal business unit, division or function (such as sales, administration or finance), or any officer or other person who performs significant policy-making functions for the Company, as determined under 17 CFR §229.401(b). The term “Executive Officers” shall include all of the



Company’s current and former executive officers who served as an executive officer at any time during the applicable performance period for the Incentive-Based Compensation. Subsequent changes in an Executive Officer’s employment status, including retirement or termination of employment, do not affect the Company’s rights to recover Incentive-Based Compensation pursuant to this Policy.
(f)Financial Reporting Measures” means (i) measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures, (ii) the Company’s stock price, and (iii) total shareholder return in respect of the Company. A “Financial Reporting Measure” need not be presented within the financial statements or included in a filing with the SEC.
(g)Incentive-Based Compensation” means any compensation that is granted, earned or vested, based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive-Based Compensation does not include, among other forms of compensation, equity awards that vest exclusively upon completion of a specified employment period, without any performance condition, and bonus awards that are based on goals unrelated to Financial Reporting Measures.
(h)NYSE” means the New York Stock Exchange LLC.
(i)Received” – Incentive-Based Compensation is deemed “Received” for the purposes of this Policy in the Company’s fiscal period during which the Financial Reporting Measure applicable to the Incentive-Based Compensation award is attained, even if the payment or grant of the Incentive-Based Compensation occurs after the end of that period.
(j)Recovery Period” means the three completed fiscal years immediately preceding the date on which the Company is required to prepare a Restatement, which date is the earlier of (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes or reasonably should have concluded, that the Company is required to prepare a Restatement or (ii) a date that a court, regulator or other legally authorized body directs the Company to prepare a Restatement.
(k)Regulators” means, as applicable, the Securities and Exchange Commission and the NYSE.
(l)Restatement” means that the Company is required to prepare an accounting restatement due to a material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements (i) that is material to the previously issued financial statements, or (ii) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
*    *    *


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:11/21/23
11/8/234
10/2/23
For Period end:9/30/23
11/28/22
9/28/18
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/07/24  Cencora, Inc.                     424B2       2/06/24    2:741K                                   Toppan Merrill/FA
 2/05/24  Cencora, Inc.                     424B5                  1:717K                                   Toppan Merrill/FA
11/22/23  Walgreens Boots Alliance, Inc.    10-K/A      8/31/23   17:513K


52 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/23  Cencora, Inc.                     8-K:1,8,9  11/09/23   11:242K                                   Toppan Merrill/FA
10/10/23  Cencora, Inc.                     8-K:1,2,9  10/06/23   11:1.2M                                   Toppan Merrill/FA
 8/30/23  Cencora, Inc.                     8-K:5,7,9   8/30/23   13:489K                                   Toppan Merrill/FA
 8/08/23  AmerisourceBergen Corp.           8-K:1,8,9   8/02/23   13:597K                                   Toppan Merrill/FA
 6/20/23  AmerisourceBergen Corp.           8-K:1,8,9   6/15/23   11:245K                                   Toppan Merrill/FA
 5/15/23  AmerisourceBergen Corp.           8-K:1,8,9   5/11/23   11:250K                                   Toppan Merrill/FA
 5/05/23  AmerisourceBergen Corp.           8-K:1,2,9   5/03/23   11:1.1M                                   Toppan Merrill/FA
12/12/22  AmerisourceBergen Corp.           8-K:1,8,9  12/08/22   11:249K                                   Toppan Merrill/FA
11/22/22  AmerisourceBergen Corp.           10-K        9/30/22  109:12M
11/10/22  AmerisourceBergen Corp.           8-K:1,8,9  11/06/22   13:552K                                   Toppan Merrill/FA
10/27/22  AmerisourceBergen Corp.           8-K:1,2,9  10/27/22   11:1.2M                                   Toppan Merrill/FA
10/24/22  AmerisourceBergen Corp.           8-K:1,2,9  10/21/22   11:1.6M                                   Toppan Merrill/FA
 8/03/22  AmerisourceBergen Corp.           10-Q        6/30/22   70:7.5M
 5/03/22  AmerisourceBergen Corp.           8-K/A:1,9   2/25/22   11:15M                                    Toppan Merrill/FA
 4/01/22  AmerisourceBergen Corp.           8-K:5,9     3/10/22   11:340K                                   Toppan Merrill/FA
 2/02/22  AmerisourceBergen Corp.           10-Q       12/31/21   67:6.5M
11/08/21  AmerisourceBergen Corp.           8-K:1,2,9  11/04/21   13:2.1M                                   Toppan Merrill/FA
 6/02/21  AmerisourceBergen Corp.           8-K:1,2,7,9 6/01/21   12:665K                                   Cravath Swaine & … 01/FA
 5/14/21  AmerisourceBergen Corp.           8-K:1,2,9   5/13/21   14:4.5M                                   Toppan Merrill/FA
 4/01/21  AmerisourceBergen Corp.           8-K:1,2,7,8 3/30/21   14:1.2M                                   Toppan Merrill/FA
 2/04/21  AmerisourceBergen Corp.           10-Q       12/31/20   63:5.2M
 1/08/21  AmerisourceBergen Corp.           8-K:1,7,9   1/06/21   14:3.6M                                   Cravath Swaine & … 01/FA
10/19/20  AmerisourceBergen Corp.           8-K:1,2,9  10/16/20   15:1.2M
 5/19/20  AmerisourceBergen Corp.           8-K:1,2,7,8 5/19/20   13:738K                                   Toppan Merrill/FA
 9/23/19  Cencora, Inc.                     8-K:1,2,9   9/18/19   16:1.9M
 1/31/19  AmerisourceBergen Corp.           10-Q       12/31/18   66:5M
 1/11/19  AmerisourceBergen Corp.           8-K:5,9     1/11/19    4:375K
11/06/18  AmerisourceBergen Corp.           8-K:1,2,9  10/31/18    4:12M
 5/02/18  AmerisourceBergen Corp.           10-Q        3/31/18   59:4.9M
 2/06/18  AmerisourceBergen Corp.           10-Q       12/31/17   55:9.4M
12/05/17  Cencora, Inc.                     8-K:1,2,7,812/04/17    5:1M                                     Toppan Merrill/FA
11/22/16  Cencora, Inc.                     8-K:1,2,9  11/18/16    5:2.1M
 6/23/16  Cencora, Inc.                     8-K:1,2,9   6/21/16    3:176K
11/04/15  Cencora, Inc.                     8-K:1,9    11/04/15    2:407K                                   Toppan Merrill/FA
 2/20/15  Cencora, Inc.                     8-K:1,2,8,9 2/20/15    5:1.1M                                   Toppan Merrill/FA
12/08/14  Cencora, Inc.                     8-K:1,9    12/05/14    2:170K                                   Toppan Merrill/FA
 7/22/14  Cencora, Inc.                     8-K:1,9     7/17/14    2:130K                                   Toppan Merrill/FA
 5/22/14  Cencora, Inc.                     8-K:1,2,7,8 5/22/14    6:1M                                     Toppan Merrill/FA
 3/10/14  Cencora, Inc.                     8-K:5,7,9   3/06/14   10:798K                                   Toppan Merrill/FA
12/05/13  AmerisourceBergen Corp.           8-K:5,9    12/01/13    2:241K                                   Toppan Merrill/FA
11/26/13  AmerisourceBergen Corp.           10-K        9/30/13   78:10M                                    Toppan Merrill-FA
10/10/13  AmerisourceBergen Corp.           8-K:1,9    10/07/13    2:596K                                   Toppan Merrill/FA
 7/03/13  AmerisourceBergen Corp.           8-K:1,9     6/28/13    2:524K                                   Toppan Merrill/FA
 3/20/13  AmerisourceBergen Corp.           8-K:1,3,7,9 3/18/13    8:2.2M                                   Toppan Merrill/FA
 2/25/13  AmerisourceBergen Corp.           8-K:8,9     2/25/13    3:222K                                   Toppan Merrill/FA
 1/17/13  AmerisourceBergen Corp.           8-K:1,9     1/16/13    2:252K                                   Toppan Merrill/FA
11/21/12  AmerisourceBergen Corp.           8-K:1,9    11/16/12    2:327K                                   Toppan Merrill/FA
10/28/11  AmerisourceBergen Corp.           8-K:1,9    10/28/11    4:641K                                   Donnelley … Solutions/FA
 5/04/11  AmerisourceBergen Corp.           8-K:1,2,9   4/28/11    4:187K                                   Donnelley … Solutions/FA
 5/05/10  AmerisourceBergen Corp.           8-K:1,2,9   4/29/10    3:719K                                   Donnelley … Solutions/FA
11/23/09  AmerisourceBergen Corp.           8-K:1,2,7,911/19/09    4:670K                                   Donnelley … Solutions/FA
11/25/08  AmerisourceBergen Corp.           10-K        9/30/08   14:2.2M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001140859-23-000197   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 1:19:04.4pm ET